Table 3. Univariate and multivariate analyses of overall survival for the FUSCC cohort.
Prognostic factor | Univariate analysis | Multivariate analysis | |||||
---|---|---|---|---|---|---|---|
P value | HR | 95% CI | P value | HR | 95% CI | ||
Age, years | <0.001 | 0.654 | 0.529–0.809 | <0.001 | 0.514 | 0.412–0.641 | |
Sex | 0.354 | 1.104 | 0.895–1.362 | – | – | – | |
Location | 0.01 | 0.765 | 0.625–0.937 | 0.041 | 0.805 | 0.654–0.992 | |
pT stage | <0.001 | 1.981 | 1.550–2.531 | 0.011 | 1.56 | 1.109–2.194 | |
pN stage | <0.001 | 2.468 | 2.175–2.801 | <0.001 | 1.878 | 1.620–2.178 | |
pM stage | <0.001 | 1.781 | 1.509–2.102 | <0.001 | 1.978 | 1.603–2.440 | |
Venous invasion | <0.001 | 1.685 | 1.508–1.883 | <0.001 | 1.492 | 1.273–1.749 | |
Perineural invasion | <0.001 | 1.493 | 1.304–1.710 | 0.009 | 1.357 | 1.079–1.707 | |
Tumor deposit | <0.001 | 3.246 | 2.607–4.042 | <0.001 | 1.78 | 1.406–2.254 |
FUSCC, Fudan University Shanghai Cancer Center; HR, hazard ratio; CI, confidence interval.